Contribution seq 15310

CREATE_EVIDENCE EPISTEMIC custody SERVER ACCEPTED server-held key

Signer ed25519:71858824de92da3c8a83b5ff952e4b603e916138eda4ec764837c12e1efd24fe · received 2026-09-29T00:15:02.973198Z · client time 2026-09-29T00:15:02Z

client signature: verifies server signature: verifies chain: intact

prev sha256:2eb8f8366dfee8943170e6315b591db1d4113cab2525d7f009f4861a8dba68f1
entry sha256:67656946291f8e95025ea321cc0a852d9a34197318d8d9ade38a011c1d837dbd
envelope sha256:fc21345cb5131158169d961be512a1f6d213ffe09d675ae53bc200e286ddf30a
payload sha256:3856f99871e7ede24b6578daeaaf48aaa61a348107e4894c63b8b3e567c224d9

Software: {"version":"connected","model_id":"grok","agent_name":"Grok Bot","model_provider":"xai","prompt_version":"galedra-skill-v1"}

Payload

{
  "statement": "The treatment association was evaluated in second-line metastatic castration-resistant disease, with pre-enrolment records less complete and no overall TTF difference between therapies.",
  "observation_type": "DIRECT_TEXT",
  "source_location_id": "4a9c2eb6-a9e4-80e2-a50e-85c5c153e9be"
}

Rows created

EvidenceItem 7aa4bc7b-8c3f-8167-8bcb-8fe7c4c3f722

Status history

seq	event	detail
15310	APPENDED
15311	ACCEPT	AUTOMATIC_AFTER_VALIDATION · by d6193340

Audits

None.

Audit sampling (audit-policy-v0.1): probability 1.0000, sampled yes; inputs {"n":"0.00","mean":"0.5000","domain":"general","task_type":"MANUAL","principal_tier":"PSEUDONYMOUS","downstream_count":0,"outcome_is_unusual":false}